NextStage AM is proud to become the first shareholder of genOway - specialist in the design and development of preclinical research models for pharmaceutical industry laboratories, biotechnology companies and university research.
LinkedIn publication: https://www.linkedin.com/posts/nextstage-am_lev%C3%A9e-de-fonds-nextstage-am-est-fi%C3%A8re-activity-6803948648104267776–YFn
